SCHEMBL28360703

SCHEMBL28360703

O=C(O)C(S)(Cc1ccccc1)[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CPA1 P15085 6/20 0.40
FDPS P14324 1/20 0.38
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
AKR1B1 P15121 1/20 0.36
LMNA P02545 1/20 0.36
CYP2D6 P10635 1/20 0.36
ARG1 P05089 1/20 0.36
ARG2 P78540 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9617912 0.78 SMN1; SMN2 (0.50) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL10717351 0.78 SMN1; SMN2 (0.50) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL4362988 0.75 SMN1; SMN2 (0.56) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL28243868 0.75 SMN1; SMN2 (0.56) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL14935688 0.75 SMN1; SMN2 (0.56) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL31165924 0.74 SMN1; SMN2 (0.46) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL19610232 0.73 FDPS (0.47) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL8331176 0.73 FDPS (0.47) SMN1; SMN2HIF1ACES2CES1CPA1
SCHEMBL10419786 0.72 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ACES2CES1FDPS
SCHEMBL28952912 0.72 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ACES2CES1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110840847-A Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases 沃泰克斯药物股份有限公司 2020-02-28 CN disclosed